Clinical Significance of Blood Lactate in the Infants with Asthmatic Disease

Bo DING,Yan-ming LU,Ya-qin LI,Ling-yun XU,Xiao-yan LI,Qing YU
DOI: https://doi.org/10.13241/j.cnki.pmb.2018.02.015
2018-01-01
Abstract:Objective:To explore the clinical significance of blood lactate in the infants with asthmatic disease.Methods:From September 2014 to April 2015,245 cases of infants diagnosed with bronchopneumonia were enrolled and divided into the asthmatic group and the non-asthmatic group.The asthmatic group was divided into A (≤ 12 month),B (12 month<age ≤ 36 month),C(36 month<age ≤ 60 month) according to the age.Asthmatic patients were then divided into the normal lactate group (<2.2 mmol/L) and increased lactate group(≥ 2.2 mmol/L).The level of blood lactate,age of onset,the therapeutic dose of glucocorticoid,days of treatment and hospitalization expenses were compared between two groups.Results:The blood lactate in sthmatic patients was obviously higher than that of the non-asthmatic patients (P<0.05).The proportion of children in the sthmatic group with lactate level between 2.2 mmol/L and 4.4 mmol/L is more than non-asthmatic group (P <0.05).The blood lactate of children with different age in the asthmatic group is significantly different.The smaller age with higher blood lactate level.Compared with normal lactate group,the age of increased lactate group was younger (P<0.05),the therapeutic dose of glucocorticoid was higher (P<0.05).But there was no significant difference in the hospital stay and hospitalization expenses (P<0.05).Conclusions:The blood lactate was obviously increased in the infants with wheeze or with younger age.It had certain relation with the therapeutic dose of glucoeorticoid used in asthmatic infants.Which made a significance in guiding the rational use ofglucocorticoid in infants with asthmatic diseases.
What problem does this paper attempt to address?